[go: up one dir, main page]

MX2022012735A - Agente para mejorar la calidad del sueño. - Google Patents

Agente para mejorar la calidad del sueño.

Info

Publication number
MX2022012735A
MX2022012735A MX2022012735A MX2022012735A MX2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A MX 2022012735 A MX2022012735 A MX 2022012735A
Authority
MX
Mexico
Prior art keywords
sleep
agent
improving quality
improving
quality
Prior art date
Application number
MX2022012735A
Other languages
English (en)
Inventor
Satomi Yamasaki
Tetsuya Sakurai
Kazuhiko Kawaguchi
Takanori Mizuno
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of MX2022012735A publication Critical patent/MX2022012735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/032—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

Se proporciona una composición farmacéutica útil que presenta efectos de mejora de la calidad del sueño, alivio del estrés y reducción de la sensación de fatiga en un blanco mamífero (por ejemplo, un ser humano) mediante la ingestión o administración de una composición que contiene al menos una sustancia seleccionada del grupo que consta de ácido cítrico y una de sus sales.
MX2022012735A 2020-04-14 2021-04-13 Agente para mejorar la calidad del sueño. MX2022012735A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020072192 2020-04-14
JP2020123385 2020-07-20
PCT/JP2021/015273 WO2021210565A1 (ja) 2020-04-14 2021-04-13 睡眠の質の改善剤

Publications (1)

Publication Number Publication Date
MX2022012735A true MX2022012735A (es) 2022-11-07

Family

ID=78084866

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012735A MX2022012735A (es) 2020-04-14 2021-04-13 Agente para mejorar la calidad del sueño.

Country Status (12)

Country Link
US (1) US20230149330A1 (es)
EP (1) EP4137206A4 (es)
JP (2) JPWO2021210565A1 (es)
KR (1) KR20230005819A (es)
CN (1) CN115397262A (es)
AU (1) AU2021257176A1 (es)
BR (1) BR112022020334A2 (es)
CA (1) CA3175207A1 (es)
IL (1) IL297227A (es)
MX (1) MX2022012735A (es)
PH (1) PH12022552709A1 (es)
WO (1) WO2021210565A1 (es)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4913410B1 (es) 1970-05-29 1974-03-30
CN1172645A (zh) * 1997-07-18 1998-02-11 杨巍 柠檬酸盐溶石液及其制备方法
KR100379596B1 (ko) * 1999-09-13 2003-04-10 주식회사 한국팜비오 구연산칼륨을 주제로 한 요로결석치료제의 제조방법
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
CN1780562B (zh) 2004-01-14 2011-04-13 味之素株式会社 含甘氨酸食品及其应用
WO2005097101A1 (ja) * 2004-04-06 2005-10-20 Taiyokagaku Co., Ltd. 睡眠改善用組成物
JP2007230954A (ja) * 2006-03-02 2007-09-13 Fancl Corp 睡眠誘導剤及びストレス性不眠症改善剤
JP2009023948A (ja) * 2007-07-19 2009-02-05 Pokka Corp ドーパミン抑制剤
JP5282202B2 (ja) * 2008-04-11 2013-09-04 成都金麒麟生物健康科技有限公司 抗ストレス剤または睡眠改善剤
JP5767103B2 (ja) * 2008-05-21 2015-08-19 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2014172892A (ja) * 2013-03-12 2014-09-22 Fujifilm Corp 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤
EP2983783B1 (en) * 2013-03-15 2021-04-21 New York University Citrate containing beverage
US20150087679A1 (en) * 2013-09-20 2015-03-26 Hany Helmi Nutritional sleep supplement
JP6976515B2 (ja) 2017-07-21 2021-12-08 国立大学法人 筑波大学 睡眠改善剤
JP7231898B2 (ja) 2018-09-26 2023-03-02 ビーエイチエヌ株式会社 睡眠の質改善剤
EP3868215A4 (en) * 2018-10-16 2022-07-27 Nippon Chemiphar Co., Ltd. SLEEP QUALITY IMPROVING AGENT
WO2020080399A1 (ja) * 2018-10-17 2020-04-23 日本ケミファ株式会社 夜間多尿の治療又は予防剤
JP7192399B2 (ja) 2018-10-31 2022-12-20 Tdk株式会社 薄膜キャパシタ
JP6815547B2 (ja) 2020-04-21 2021-01-20 株式会社フジタ 床振動解析プログラムおよび床振動解析装置

Also Published As

Publication number Publication date
KR20230005819A (ko) 2023-01-10
JP2025172167A (ja) 2025-11-20
BR112022020334A2 (pt) 2022-11-22
AU2021257176A1 (en) 2022-11-10
IL297227A (en) 2022-12-01
US20230149330A1 (en) 2023-05-18
EP4137206A1 (en) 2023-02-22
CN115397262A (zh) 2022-11-25
JPWO2021210565A1 (es) 2021-10-21
PH12022552709A1 (en) 2024-04-22
EP4137206A4 (en) 2024-05-22
WO2021210565A1 (ja) 2021-10-21
CA3175207A1 (en) 2021-10-21

Similar Documents

Publication Publication Date Title
Van Bellinghen et al. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial
Sher et al. Acute myopathy with selective lysis of myosin filaments
JP2020073606A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
Bloomfield et al. Cocoa flavanols protect cognitive function, cerebral oxygenation, and mental fatigue during severe hypoxia
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
AU2013339058B2 (en) Agent for preventing or improving decline in brain function
PH12022552709A1 (en) Agent for improving quality of sleep
WO2007057748A2 (en) Use of colostrum for the prophylaxis of influenza syndromes
WO2020170032A3 (en) Method for treatment of rosacea in patients aged 65 years and older
Bear et al. β-hydroxy-β-methylbutyrate supplementation in older persons–an update
US10973919B2 (en) Vitamin preparation
CR20230472A (es) Inhibidores de integrina alpha v beta 6 y alpha v beta 1 y sus usos
JP2011098961A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2003073303A (ja) 眼局所用液剤の清涼化作用の持続方法
JP2017071600A (ja) くすぶり炎症抑制剤
Toronto Aerosolized Pentamidine Study (TAPS) Group Acute pulmonary effects of aerosolized pentamidine: a randomized controlled study
Ferrer et al. A nasal spray solution of grapefruit seed extract plus xylitol displays virucidal activity against SARS-Cov-2 in vitro
DE04291738T1 (de) Verwendung von Citrullin zur Herstellung eines Arzneimittels zur Behandlung von intestinaler Insuffizienz
KR100880537B1 (ko) 칸탈로프 멜론추출물과 글리아딘 결합물을 유효성분으로 하는 기억, 집중력, 학습능력 개선제
US6270756B1 (en) Weight loss induced by alpha interferon and gamma interferon
Sagdullayevna et al. Hypomenstrual Syndrome in Adolescent Girls in the Context of the Covid-19 Pandemic
US20210260039A1 (en) Nutritional compositions for enhancement of muscle performance
Ciświcka-Sznajderman et al. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia
Torres-Larrosa et al. Nasal leprosy: impact of multitherapy in the morphology and physiology of the nose
US20160361333A1 (en) Use of citrus polyphenol for wound healing and composition thereof